Parker C W, Smith J W
J Clin Invest. 1973 Jan;52(1):48-59. doi: 10.1172/JCI107173.
In an effort to better define the role of betaadrenergic blockade in human bronchial asthma, peripheral blood leukocytes and lymphocytes from individuals with this condition were studied for possible alterations in cyclic AMP metabolism. Using a previously described radioimmunoassay to measure cyclic AMP, cells from asthmatic subjects were shown to have a highly significant decrease in their cyclic AMP response to beta-adrenergic agents (isoproterenol, norepinephrine, and epinephrine) by comparison with normal control cells. The alteration in responsiveness was most marked at the time of severe active asthma and returned toward normal during periods of clinical remission. Evidence was presented to indicate that the reduced response in cells from asthmatic individuals was not due to marked alterations in the proportion of T and B lymphocytes. Five normal volunteers were treated with an oral bronchodilator preparation containing theophylline and ephedrine over a 2 wk period without a significant change in the lymphocyte cyclic AMP response. These results provide unambiguous evidence for altered adrenergic responsiveness in bronchial asthma and indicate that purified peripheral blood lymphocytes should be a suitable in vitro system for further elucidation of the abnormality. Despite the reduction in catecholamine responsiveness in the asthmatic population as a whole, major alterations were largely restricted to individuals with severe, chronic asthma. Conclusive evidence for beta-adrenergic blockade in individuals who have not had recent asthmatic symptoms was not obtained, casting some doubt on the theory that bronchial asthma is due to a congenital derangement of cyclic AMP metabolism. Moreover, transient episodes of bronchospasm were often accompanied by a normal cyclic AMP response indicating that episodes of asthma frequently occur in the absence of easily demonstrable adrenergic blockade.
为了更好地确定β肾上腺素能阻滞剂在人类支气管哮喘中的作用,对患有这种疾病的个体的外周血白细胞和淋巴细胞进行了研究,以寻找环磷酸腺苷(cAMP)代谢可能存在的改变。使用先前描述的放射免疫测定法来测量cAMP,结果显示,与正常对照细胞相比,哮喘患者的细胞对β肾上腺素能药物(异丙肾上腺素、去甲肾上腺素和肾上腺素)的cAMP反应显著降低。这种反应性的改变在严重活动性哮喘发作时最为明显,在临床缓解期则恢复正常。有证据表明,哮喘患者细胞反应性降低并非由于T淋巴细胞和B淋巴细胞比例的显著改变。五名正常志愿者在两周内接受了含有茶碱和麻黄碱的口服支气管扩张剂治疗,淋巴细胞的cAMP反应没有明显变化。这些结果为支气管哮喘中肾上腺素能反应性改变提供了明确证据,并表明纯化的外周血淋巴细胞应是进一步阐明这种异常的合适体外系统。尽管哮喘患者总体上对儿茶酚胺的反应性降低,但主要改变大多局限于患有严重慢性哮喘的个体。对于近期没有哮喘症状的个体,未获得β肾上腺素能阻滞的确凿证据,这对支气管哮喘是由于cAMP代谢先天性紊乱这一理论提出了一些质疑。此外,支气管痉挛的短暂发作常伴有正常的cAMP反应,这表明哮喘发作频繁发生时,往往没有易于证明的肾上腺素能阻滞。